Skip to main content

Animations

MJFF Publications

6071 - 6080 of 7939 Results
Title
Year
  • Year
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • RESTRICTED
    Title: Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.03.017
    Best OA location URL:
    Citation Count: 60
  • RESTRICTED
    Title: Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26976
    Best OA location URL:
    Citation Count: 29
  • OPEN
    Title: The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease
    Journal Name: Biomarkers in Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2217/bmm-2016-0366
    Citation Count: 48
  • RESTRICTED
    Title: The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging Studies
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26964
    Best OA location URL:
    Citation Count: 52
  • OPEN
    Title: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1616874114
    Citation Count: 67
  • OPEN
    Title: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897
    Citation Count: 77
  • OPEN
    Title: Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0012-6
    Citation Count: 33
  • OPEN
    Title: LRRK2 levels in immune cells are increased in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0010-8
    Citation Count: 212
  • OPEN
    Title: The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1042/bcj20160909
    Citation Count: 33
  • OPEN
    Title: An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression
    Journal Name: PROTEOMICS – Clinical Applications
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/prca.201700045
    Citation Count: 16
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.